NuCana (NCNA) Total Non-Current Liabilities (2017 - 2025)
NuCana's (NCNA) quarterly Total Non-Current Liabilities came in at $949738.7 in Q4 2025, up 380.49% year-on-year from $197659.3 in Q4 2024, and up 496.48% quarter-over-quarter from $159224.7 in Q3 2025.
NuCana (NCNA) Total Non-Current Liabilities (2017 - 2025) Analysis & Trends
NuCana has disclosed Total Non-Current Liabilities across 9 years of filings, most recently posting $949738.7 for Q4 2025.
- Total Non-Current Liabilities for Q4 2025 came in at $949738.7, up 380.49% year-over-year; the trailing twelve-month figure through Dec 2025 was $949738.7 (up 380.49% YoY), and the FY2025 annual result was $941416.4, up 378.23% from the prior year.
- Total Non-Current Liabilities came in at $949738.7 for Q4 2025 at NuCana, up from $159224.7 in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $949738.7 in Q4 2025 to a low of $159224.7 in Q3 2025.
- The 5-year median for Total Non-Current Liabilities is $299782.4 (2023), against an average of $352188.9.
- Across the five-year window, Total Non-Current Liabilities sank 48.09% in 2021 and surged 380.49% in 2025, its largest moves.
- NuCana's Total Non-Current Liabilities stood at $283082.2 in 2021, then soared by 83.14% to $518434.3 in 2022, then plunged by 40.63% to $307805.7 in 2023, then slumped by 35.78% to $197659.3 in 2024, then soared by 380.49% to $949738.7 in 2025.
- The last three Total Non-Current Liabilities figures came in at $949738.7 (Q4 2025), $159224.7 (Q3 2025), and $182764.3 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 42,980.09 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 11.03 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 95.20 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 5.87 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 64.76 Mn |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - | 949,738.67 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 949,738.67 |
| Sep 30, 2025 | 159,224.73 |
| Jun 30, 2025 | 182,764.26 |
| Mar 31, 2025 | 171,292.07 |
| Dec 31, 2024 | 197,659.28 |
| Sep 30, 2024 | 213,085.23 |
| Jun 30, 2024 | 267,590.80 |
| Mar 31, 2024 | 291,759.18 |
| Dec 31, 2023 | 307,805.67 |
| Sep 30, 2023 | 354,671.74 |
| Jun 30, 2023 | 421,709.38 |
| Mar 31, 2023 | 481,341.77 |
| Dec 31, 2022 | 518,434.32 |
| Sep 30, 2022 | 595,166.89 |
| Jun 30, 2022 | 206,527.53 |
| Mar 31, 2022 | 250,923.28 |
| Dec 31, 2021 | 283,082.23 |
| Sep 30, 2021 | 332,238.59 |
| Jun 30, 2021 | 387,170.73 |
| Mar 31, 2021 | 471,590.91 |